Cancer News and Research

Latest Cancer News and Research

Herceptin therapy highly superior to standard breast cancer treatment

In a joint paper, co-authored by Mayo Clinic's Edith Perez, M.D., and Edward Romond, M.D., of the National Surgical Adjuvant Breast and Bowel Project (NSABP), researchers report complete and combined results of two trials comparing adjuvant chemotherapy with or without concurrent trastuzumab treatment in women with surgically removed HER2-positive breast cancer.

19 Oct 2005

Majority of women with breast cancer do not need chemotherapy

Researchers are now saying that chemotherapy with drugs called aromatase inhibitors is unnecessary after lumpectomy, radiation and 5 years of Tamoxifen, for the vast majority of women with breast cancer.

19 Oct 2005

Court victory means breast cancer drug Herceptin will be available to more women

The court victory of British woman Barbara Clark to be treated with the breast cancer drug Herceptin, means that now more than 100 breast cancer patients in Cornwall and Devon could soon be prescribed the drug.

19 Oct 2005

Conjugated linoleic acid prevents inflammatory damage resulting from immune response

One of the isomers of conjugated linoleic acid, a group of fatty acids found in milk, is a natural regulator of the COX-2 protein, which plays a significant role in inflammatory disease such as arthritis and cancer, according to a study published by University of Wisconsin-Madison researchers.

18 Oct 2005

Patients with head and neck cancer may be spared the risk and expense of surgery by undergoing a CT scan

Researchers with the UF Shands Cancer Center have identified criteria doctors can use to evaluate CT scans four weeks after patients undergo initial treatment. If these criteria are met, there is a 94 percent likelihood a patient's lymph nodes are cancer free, said Stanley L. Liauw, M.D., a resident in radiation oncology.

18 Oct 2005

Access to genetic counseling and testing are an important part of cancer control

Ten years after the identification of the first breast cancer susceptibility genes so few high-risk minority women have received genetic counseling or testing that the standard methods of calculating risk have not been validated in these groups and the results of genetic testing can still produce surprises.

18 Oct 2005

Data supports use of personal and family history of breast cancer, ovarian cancer, or both in making clinical decisions

African American women at high-risk of breast cancer have genetic mutations that would make genetic testing feasible, according to a study in the October 19 issue of JAMA: The Journal of the American Medical Association.

18 Oct 2005

Yeast cells help show how GSAO (glutathionarsenoxide) angiogenesis inhibitor drug works

The humble yeast has revealed the molecular workings of an anti-cancer drug that stops the growth and spread of tumours in humans by starving their blood supply.

18 Oct 2005

Intensity modulated radiation therapy (IMRT) for head and neck cancer

Results from a University of Pittsburgh study evaluating intensity modulated radiation therapy (IMRT) for head and neck cancer determined the ideal doses for lessening treatment side effects. The findings were presented today at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Denver.

18 Oct 2005

Health insurers are turning to a new approach to get doctors and hospitals to do better

In this approach, insurers offer financial rewards for better or more efficient care and sometimes create penalties for poor performance. Even though it has become commonplace, there is little evidence about its impact on care, says R. Adams Dudley, MD, MBA, a professor in the UCSF Institute for Health Policy Studies and the Department of Medicine.

18 Oct 2005

Treating malignant melanoma of the uvea with radiation therapy can spare patients from significant vision loss

Treating a rare form of eye cancer with radiation therapy can spare patients from significant vision loss, according to new research at Wake Forest University Baptist Medical Center.

18 Oct 2005

Possible new combination treatment regimen for patients with head and neck cancers who develop a second tumor

Few treatment options exist for patients with head and neck cancers who develop a second tumor or whose disease recurs in an area that has previously received radiation. Data from an international study reveal a possible new combination treatment regimen that offers a significant survival advantage for many of these patients.

18 Oct 2005

Treating four or more brain tumors in a single radiosurgery session resulted in improved survival

...compared to whole brain radiation therapy alone, according to a study the University of Pittsburgh School of Medicine presented today at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Denver.

18 Oct 2005

People who carry a mutation in the melanoma susceptibility gene CDKN2A have a much lower risk of melanoma

In addition, most familial clusters of melanoma occur in families without identifiable mutations in this gene, according to a new study that appears in the October 19 issue of the Journal of the National Cancer Institute.

18 Oct 2005

Radical prostatectomy may be a safe option for the treatment of prostate cancer

Prostate cancer is the most common non-skin cancer in American men and the third most common cause of cancer death. In patients with localized disease, radical prostatectomy is associated with lower disease-specific mortality, lower rates of local progression and metastases, and higher overall survival compared with conservative management.

18 Oct 2005

Single men are less likely to seek radiation re-treatment for pain caused by prostate cancer

"Patients often experience a great deal of pain if their cancer spreads to the bone," explained Andre Konski, M.D., M.B.A., M.A., F.A.C.R., director of clinical research in the radiation oncology department at Fox Chase Cancer Center and lead author of the paper on the Radiation Therapy Oncology Group study (RTOG 97-14).

18 Oct 2005

Cutting-edge research to develop this range of next-generation biomedical devices

Revolutionary new self-diagnostic devices to provide early warning of deadly and debilitating illnesses like cancer, diabetes and heart disease are the aim of a Euro 22.5m Science Foundation Ireland research facility to be established at Dublin City University.

18 Oct 2005

No evidence of a "safe" threshold with environmental toxins

Four of the most widespread environmental toxins - lead, trihalomethanes (found in drinking water), ionizing radiation from indoor radon gas, and tobacco smoke - can cause serious damage to health even at very low levels, say researchers in the open access journal PLoS Medicine.

18 Oct 2005

New prostate cancer test far more accurate

At present in order to predict prostate cancer outcomes, doctors rely on measures that suggest how far the tumour has spread and how abnormal the cancer cells appear under the microscope.

18 Oct 2005

Cannabis smoke less likely to cause cancer than tobacco smoke

According to a leading U.S. expert, cannabis smoke is less likely to cause cancer than tobacco smoke.

18 Oct 2005

Cancer News and Research

Latest Cancer News and Research

Herceptin therapy highly superior to standard breast cancer treatment

Majority of women with breast cancer do not need chemotherapy

Court victory means breast cancer drug Herceptin will be available to more women

Conjugated linoleic acid prevents inflammatory damage resulting from immune response

Patients with head and neck cancer may be spared the risk and expense of surgery by undergoing a CT scan

Access to genetic counseling and testing are an important part of cancer control

Data supports use of personal and family history of breast cancer, ovarian cancer, or both in making clinical decisions

Yeast cells help show how GSAO (glutathionarsenoxide) angiogenesis inhibitor drug works

Intensity modulated radiation therapy (IMRT) for head and neck cancer

Health insurers are turning to a new approach to get doctors and hospitals to do better

Treating malignant melanoma of the uvea with radiation therapy can spare patients from significant vision loss

Possible new combination treatment regimen for patients with head and neck cancers who develop a second tumor

Treating four or more brain tumors in a single radiosurgery session resulted in improved survival

People who carry a mutation in the melanoma susceptibility gene CDKN2A have a much lower risk of melanoma

Radical prostatectomy may be a safe option for the treatment of prostate cancer

Single men are less likely to seek radiation re-treatment for pain caused by prostate cancer

Cutting-edge research to develop this range of next-generation biomedical devices

No evidence of a "safe" threshold with environmental toxins

New prostate cancer test far more accurate

Cannabis smoke less likely to cause cancer than tobacco smoke

Understanding the DNA Damage Response in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in